Does postmenopausal hormone therapy cause urinary incontinence?
Rivera
Rolando
R
University of Miami, FL, USA.
Gousse
Angelo
A
D000369:Aged, 80 and over; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D004967:Estrogens / Q000009:adverse effects* / Q000627:therapeutic use; D004966:Estrogens, Conjugated (USP) / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006331:Heart Diseases / Q000517:prevention & control*; D006801:Humans; D015994:Incidence; D017258:Medroxyprogesterone Acetate / Q000009:adverse effects* / Q000627:therapeutic use; D017698:Postmenopause; D012189:Retrospective Studies; D012307:Risk Factors; D014549:Urinary Incontinence / Q000139:chemically induced* / Q000453:epidemiology / Q000503:physiopathology; D014563:Urodynamics / Q000187:drug effects
D004967:Estrogens; D004966:Estrogens, Conjugated (USP); D017258:Medroxyprogesterone Acetate